WHO issues alert against substandard oral cough syrups in India
NEW DELHI, Oct 14 (PTI): The World Health Organisation (WHO) has issued an alert against three “substandard” oral cough syrups identified in India — Coldrif, Respifresh TR and ReLife — and urged national regulatory authorities worldwide to immediately notify it if these are detected in their country.
It has also advised healthcare professionals to report the detection of these substandard products and any incident of adverse effects, or lack of expected effects to their national regulatory authorities or National Pharmacovigilance Centre.
The alert comes after at least 22 children, mostly under the age of five, have died due to suspected kidney failure after being administered Coldrif in Madhya Pradesh. Besides, at least three children have allegedly died in Rajasthan after consuming cough syrup in different districts of the state.
